期刊文献+

国产替罗非班在急性心肌梗死介入治疗中的应用分析 被引量:1

Application of Tirofiban in Percutaneous Coronary Intervention of Acute Myocardial Infarction
下载PDF
导出
摘要 【目的】研究国产替罗非班(欣维宁)在急性ST段抬高型心肌梗死患者行急诊直接经皮冠状动脉介入治疗(PCI)的疗效及安全性。【方法】入选2011~2012年急性ST 段抬高型心肌梗死患者46例,随机分为观察组和对照组各23例,观察组患者于冠脉造影(CAG)后PCI前持续静脉给予欣维宁,并追加肝素50 U/kg静脉注射,而对照组仅追加肝素100 U/kg静脉注射;比较两组患者罪犯血管开通情况,前向血流心肌梗死溶栓治疗试验分级(TIMI)及校正的T IM L计帧数;比较治疗前后48 h检查心电图变化及不良反应。【结果】观察组TIMI 3级获得率高于对照组(87%和74%,P<0.05),梗死的TIML计帧数(CTFC)明显低于对照组(22.5±4.6帧vs30.1±6.5帧,P<0.05),治疗后48h检查心电图相关导联ST段回落幅度较对照组大(P<0.05),缺血导联个数显著低于对照组(P <0.05),两组出血率无统计学意义(P >0.05)。【结论】急性心肌梗死患者急诊直接PCI术中联合应用欣维宁安全有效。 [Objective] To explore the efficacy and safety of domestic tirofiban in percutaneous coronary intervention(PCI) of patients with ST‐elevation myocardial infarction (STEMI) .[Methods] A total of 46 pa‐tients with STEMI from 2011 to 2012 were randomly divided into observation group ( n = 23) and control group( n=23) .The observation group was given continuously intravenous injection of tirofiban after coronary angiography(CAG) and before PCI ,and additional injection of heparin 50U/kg intravenously ,while the con‐trol group was given additional injection of heparin 100 u/kg intravenously .The patency of the diseased ves‐sels ,thrombolysis of anterior blood flow myocardial infarction trial classification (TIMI) and the corrected TIML number were compared between two groups .The 48h‐electrocardiogram change and adverse reaction before and after treatment were compared .[Results]The achievement ratio of TIMI grade 3 in observation group was higher than that in control group(87% vs .74% ,P〈0 .05) .The infracted TIML number in obser‐vation group was obviously lower than that in control group [(22 .5 ± 4 .6) vs (30 .1 ± 6 .5) ,P 〈0 .05] .The falling extent of electrocardiogram‐related lead ST‐segment was obviously higher than that in control group( P〈0 .05) .The number of ischemic lead in observation group was significantly lower than that in control ( P〈0 .05) .There was no significant difference in hemorrhage rate between two groups ( P 〉0 .05) .[Conclusion]Tirofiban for the treatment of acute myocardial infarction during emergency direct PCI is safe and effective .
出处 《医学临床研究》 CAS 2014年第10期1983-1985,共3页 Journal of Clinical Research
关键词 酪氨酸/类似物和衍生物 心肌梗死/治疗 急性病 血管成形术 经腔 经皮冠状动脉 Tyrosine/AA Myocardial Infarction/TH Acute Disease Angioplasty,Translumi-nal,Percutaneous Coronary
  • 相关文献

参考文献10

  • 1陈玉国,孙祎,张运,徐峰,吕瑞娟,李瑞建.氯吡格雷对非ST抬高急性冠脉综合征病人炎症因子及其预后的影响[J].中国新药与临床杂志,2006,25(6):413-416. 被引量:13
  • 2赵京林,杨跃进,吴永建,荆志成,尤士杰,杨伟宪,孟亮,田毅,陈纪林,高润林,陈在嘉.抗血小板药物对猪急性心肌梗死再灌注后无再流的影响[J].中华医学杂志,2005,85(31):2187-2191. 被引量:20
  • 3Rezkalla SH, Kloner RA. No-reflow phenomenon[J]. Circulation, 2002, 105(5): 656-662,.
  • 4Valgimigli M. Tirofiban and sirolimus-eluting stent vs abcix- imab and bare-metal stent for acute myocardial infarction: a randomized trial[J]. JAMA, 2005, 293(17) : 2109-2117.
  • 5Heitzer, T Ollmann, I Koke, et al . Platelet glycoprotein II b/Ill a receptor blockade improves vascular nitric oxide bio- availability in patients with coronary artery disease [J]. Circulation, 2003, 108(5) : 536-541.
  • 6Warnholtz A,Ostad MA, Heitzer T, et al . Effect of Tirofi- ban on percutaneous coronary intervention-induced endotheli- al dysfunction in patients with stable coronary artery disease [J]. Am J Cardiol, 2005, 95(1): 20-23.
  • 7Elliott MA. The TIMI Risk Score for unstable angina/non- STElevationMI : a method for prognostication and therapeutic decision making [J]. JAMA, 2000, 284(7): 835-842.
  • 8The platelet receptor inhibition for ischemic syndrome man- agement in patients limited by unstable signs and symptoms (PRISM-PLUS) trial investigators. Inhibition of the platelet glycoprotein II b/Ill a receptor with tirofiban in unstable angi- na and non-Q-wave myocardial infarction [J]. N Engl J Med, 1998, 338(21) : 1488-1497.
  • 9The platelet receptor inhibition for ischemic syndrome man- agement (PRISM) study investigators. A comparison of aspi- rin plus tirofiban with aspirin plus heparin for unstable angian [J]. N Engl J &led, 1998, 338(21): 1498-1505.
  • 10谭红红,戈之铮,高云杰,陈慧敏,陈海英,房静远,刘文忠,萧树东.Dll4/Notch1在消化道血管发育不良出血患者中的表达以及沙利度胺的干预机制[J].胃肠病学,2010,15(11):646-649. 被引量:8

二级参考文献47

  • 1赵京林,杨跃进,尤士杰,荆志成,吴永健,杨伟宪,孟亮,田毅,陈纪林,高润霖,陈在嘉.地尔硫卓对猪急性心肌梗死再灌注后无再流的影响[J].中华医学杂志,2005,85(10):679-683. 被引量:7
  • 2Regula J, Wronska E, Pachlewski J. Vascular lesions of the gastrointestinal tract. Best Pract Res Clin Gastroenterol, 2008, 22 (2): 313-328.
  • 3Junquera F, Saperas E, de Torres I, et al. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol, 1999, 94 (4): 1070- 1076.
  • 4Bauditz J, Lochs H, Voderholzer W. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Endoscopy, 2006, 38 (10): 1036-1039.
  • 5Dabak V, Kuriakose P, Kamboj G, et al. A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias. Dig Dis Sci, 2008, 53 (6): 1632-1635.
  • 6Heidt J, Langers AM, van der Meer FJ, et al. Thalidomide as treatment for digestive tract angiodysplasias. Neth J Med, 2006, 64 (11): 425-428.
  • 7Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin, 2010, 60 (4): 222-243.
  • 8Kume T. Novel insights into the differential functions of Notch ligands in vascular formation. J Angiogenes Res, 2009, 1: 8.
  • 9Patel NS, Li JL, Generali D, et al. Up-regulation of delta- like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res, 2005, 65 (19): 8690-8697.
  • 10Hainaud P, Contrerbs JO, Villemain A, et al. The role of the vascular endothelial growth factor-Delta-like 4 ligand/ Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Res, 2006, 66 (17): 8501-8510.

共引文献33

同被引文献8

  • 1Poh KK, Xu X,Chan MY, et al . Safety of combination therapy with milrinone and esmolol for heart protection during percuta- neous coronary intervention in acute myocardial infarction[J]. Eur J Pharmacol, 2014, 70(5) : 527-530.
  • 2Ghatak T,Samanta S. Methanol toxicity following esmolol in- fusion in a post-operative case of pheochromoeytoma resection [J]. Saudi J Anaesth, 2013, 7(4): 484-485.
  • 3Quintana-Villamandos B, Delgado-Martos MJ, Sanchez-Her nandez J, et al . Early regression of left ventricular hypertro- phy after treatment with esmolol in an experimental rat model of primary hypertension [J]. Hypertens Res, 2013, 36 (5) .. 408-413.
  • 4Tereshchenko SN, Kositsyna IV, Dzhaiani NA, et al. The use of esmolol in patients with myocardial infarction complicat- ed with acute left ventricular failure[J]. Kardiologiia, 2005, 45(6) .. 19-22.
  • 5Hanei V, Yurtlu S, Karabag T, et al . Effects of esmolol, li- docaine and fentanyl on P wave dispersion, QT, QTc intervals and hemodynamic responses to endotracheal intubation during propofol induction: a comparative study E J]. Braz J Aanestesiol, 2013, 63(3) :235-244.
  • 6Pizarro G, Fernandez-Friera L, Fuster V, et al . Long-term benefit of earl.y pre-reperfusion metoprolol, adm.nistration in patients with acute myocardial infarction., results from the ME- TOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) [J ]. J Am Coll Cardiol, 2014, 63(22): 2356-2362.
  • 7Shams T, E1 Bahnasawe NS, Abu-Samra M, et al . Induced hypotension for functional endoscopic sinus surgery: A corn parative study of dexmedetomidine versus esmolol [J]. Saudi J Anaesth, 2013, 7(2) : 175-180.
  • 8苏文亭,黄燕,张宇辉,周琼,韦丙奇,邹长虹,安涛,郭潇,吕蓉,张健.静脉注射艾司洛尔治疗急性心肌梗死并发急性心力衰竭的疗效及安全性[J].中国心血管杂志,2012,17(1):15-17. 被引量:24

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部